APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,320 | -33.8% | 1,664,572 | +58.5% | 2.72% | -8.4% |
| Q2 2023 | $95,661 | +19.2% | 1,050,067 | -13.7% | 2.96% | -37.8% |
| Q1 2023 | $80,228 | +72.4% | 1,216,312 | +35.1% | 4.77% | +83.5% |
| Q4 2022 | $46,539 | -99.9% | 900,000 | -10.0% | 2.60% | -10.9% |
| Q3 2022 | $68,300,000 | +572.1% | 1,000,000 | +400.0% | 2.92% | +585.9% |
| Q1 2022 | $10,162,000 | +73.7% | 200,000 | -33.3% | 0.42% | +77.8% |
| Q1 2019 | $5,850,000 | – | 300,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |